The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses

Cardiovascular Diseases Clinical Trial

— WALK  

Official title:

The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04524572
• Other study ID #: 20130429
• Status: Completed
• Phase: N/A
• Start date: November 26, 2013
• Est. completion date: August 1, 2015

Study information

• Verified date: September 2023
• Source: Ottawa Heart Institute Research Corporation
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this prospective randomized controlled trial is to explore the role of a motion sensor with accompany web application on step counts, energy balance, and metabolic markers in nurses. Additionally, eating behaviours, behavioural regulation in exercise, and mood states that may impact these parameters will also be examined.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 76
• Est. completion date: August 1, 2015
• Est. primary completion date: April 25, 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• 1. Participant must be a registered nurse with the University of Ottawa Heart Institute;

2. Participant must be 18 years of age or older;

3. Participant must be able to walk unassisted;

4. Participant is able and willing to provide informed consent.

Exclusion Criteria:

1. Participant is pregnant, lactating or planning to become pregnant during the study period;

2. Participant is unable to read and understand English;

3. Medical contraindications to exercise;

4. Already using a motion sensor device to track physical activity. -

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Cardiovascular Risk Factor

Intervention

Behavioral:
• Motion sensor
To explore the role of a motion sensor with accompanying web application on step counts, energy balance, and metabolic markers in nurses

Locations

Country	Name	City	State
Canada	University of Ottawa Heart Institute	Ottawa	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
Ottawa Heart Institute Research Corporation

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Step counts	All participants will be asked to wear a Tractivity® motion sensor device on their ankle for to assess their daily step count and physical activity energy expenditure	6 weeks during observation and 6 weeks during intervention
Secondary	Body Mass (kg)	Body weight will be measured using a digital scale to the nearest 0.1 kilogram	Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52
Secondary	Waist Circumference	Waist circumference will be measured using a tape measure	Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52
Secondary	Fat mass	Fat mass will be measured using bioelectrical impedance analysis	Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52